Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …

Positron emission tomography (PET) is a radiotracer imaging method that yields quantitative
images of regional in vivo biology and biochemistry. PET, now used in conjunction with …

Importance The presence of pelvic nodal metastases at radical prostatectomy is associated
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …

Purpose: Current FDA-approved imaging modalities are inadequate for localizing prostate
cancer biochemical recurrence (BCR). 18F-DCFPyL is a highly selective, small-molecule …

Background Molecular imaging is increasingly used to guide treatment decisions and
planning in prostate cancer. We aimed to evaluate the role of 18 F-fluciclovine-PET/CT in …

PURPOSE Provide evidence-and expert-based recommendations for optimal use of
imaging in advanced prostate cancer. Due to increases in research and utilization of novel …

Purpose: Sensitive detection of cancer foci in men experiencing biochemical recurrence
following initial treatment of prostate cancer is of great clinical significance with a possible …

Prostate cancer–specific positron emission tomography (pcPET) has been shown to detect
sites of disease recurrence at serum prostate-specific antigen (PSA) levels that are lower …

Purpose To compare the diagnostic performance of the synthetic amino acid analogue PET
radiotracer anti-3-[18 F] FACBC (fluciclovine) with that of CT in the detection of recurrent …

Background Accurate staging of patients with prostate cancer (PC a) is important for
therapeutic decision‐making. Relapse after surgery or radiotherapy of curative intent is not …